Archive: 28/04/2017

Brineura approved for rare genetic illness affecting kids

(HealthDay)—Brineura (cerliponase alfa) has been approved by the U.S. Food and Drug Administration to treat a specific form of Batten Disease, a rare set of genetic disorders that typically begin in childhood between ages ...

page 1 from 6